CTOs on the Move

LensCrafters

www.lenscrafters.com

 
LensCrafters is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Neovasc

Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace.

Episode Solutions

Episode Solutions provides resources and services, tailored exclusively to the needs of musculoskeletal physicians and physicians groups, to help evaluate and maximize physician performance in alternative payment structures, without sacrificing existing professional fee-for-service revenue. Episode Solutions provides the platform that enables MSK physicians to take advantage of the substantial opportunities to create and share in immediate savings through bundled payments.

OrthoSupply Management

OrthoSupply Management is a Marlborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

medikmark

Medikmark, Inc. was founded in 1987, and is now under the ownership of David H. Sanders. Medikmark is an FDA registered manufacturer maintaining a Class 100,000 clean room and 10,000 clean room and is a licensed drug wholesaler. Medikmark is also a small

HeartBeam

HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack